Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma
โ Scribed by Zuo-Lin Xiang; Zhao-Chong Zeng; Zhao-You Tang; Jia Fan; Hui-Chuan Sun; Yun-Shan Tan
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 605 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0301-4851
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND. Few studies have investigated the pathologic types and prognosis of hepatocellular carcinoma (HCC) with lymph node metastasis (LNM). The purpose was to explore pathologic types and pertinent therapy of HCC with LNM. ## METHODS. An immunohistochemical study for CK19 and
Matrix metalloproteinase 2 (MMP-2) plays a crucial role in invasion and metastasis of malignant tumors. Membrane type 1-MMP (MT1-MMP) was originally identified as an activator of MMP-2. Tissue inhibitor of MMP-2 (TIMP-2) was identified as an inhibitor of MMP-2 and MT1-MMP. However, TIMP-2 was report
Background. Laminin-5 (Ln-5) cleaved by membrane type 1-matrix metalloproteinase (MT1-MMP) enhances the migration of tumor cells. The purpose of this study was to determine whether or not enhanced expression of both Ln-5 and MT1-MMP was associated with lymph node metastasis in patients with T1 and T
## Background: Recent studies on the role of bcl-2 in malignant tumors have suggested its prognostic significance. the goals of the current study were to determine any correlation between bcl-2 expression in esophageal squamous cell carcinoma and histopathology, lymph node metastasis, and clinical